Literature DB >> 22573107

Effects of antihypertensive drugs on arterial stiffness.

Tanja Dudenbostel1, Stephen P Glasser.   

Abstract

In this review, we discuss the possible pathophysiological mechanisms and the role of arterial stiffness as a biomarker, a blood pressure-independent predictor of cardiovascular morbidity and mortality. The effects of different antihypertensive drug classes on noninvasively assessed markers of arterial stiffness are also discussed. Current evidence will be reviewed regarding the effect of drugs on arterial stiffness, including the peripheral and central effects of angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, dihydropyridine calcium channel blockers, beta blockers (including vasodilating beta blockers), diuretics, and mineralocorticoid antagonists.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22573107      PMCID： PMC3816577          DOI： 10.1097/CRD.0b013e31825d0a44

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN： 1061-5377            Impact factor:   2.644


  49 in total

1.  Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare.

Authors:  Norman M Kaplan
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

2.  Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

Authors:  Alison J Deary; Anne L Schumann; Helen Murfet; Stephen F Haydock; Roger S-Y Foo; Morris J Brown
Journal:  J Hypertens       Date:  2002-04       Impact factor: 4.844

Review 3.  Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.

Authors:  Ernesto L Schiffrin
Journal:  Am J Hypertens       Date:  2004-12       Impact factor: 2.689

4.  Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.

Authors:  Zahid Dhakam; Carmel M McEniery; John R Cockcroft; Morris J Brown; Ian B Wilkinson
Journal:  Am J Hypertens       Date:  2006-02       Impact factor: 2.689

5.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.

Authors:  Wilbert S Aronow; Jerome L Fleg; Carl J Pepine; Nancy T Artinian; George Bakris; Alan S Brown; Keith C Ferdinand; Mary Ann Forciea; William H Frishman; Cheryl Jaigobin; John B Kostis; Giuseppi Mancia; Suzanne Oparil; Eduardo Ortiz; Efrain Reisin; Michael W Rich; Douglas D Schocken; Michael A Weber; Deborah J Wesley
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Authors:  Hong Lu; Debra L Rateri; David L Feldman; Richard J Charnigo; Akiyoshi Fukamizu; Junji Ishida; Elizabeth G Oesterling; Lisa A Cassis; Alan Daugherty
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

Authors:  G M London; B Pannier; A P Guerin; S J Marchais; M E Safar; J L Cuche
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.

Authors:  Xiong-Jing Jiang; Michael F O'Rourke; Yu-Qing Zhang; Xin-Ye He; Li-Sheng Liu
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

Review 10.  Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

Authors:  John J V McMurray; William T Abraham; Kenneth Dickstein; Lars Køber; Barry M Massie; Henry Krum
Journal:  Eur J Heart Fail       Date:  2012-04       Impact factor: 15.534
View more
  39 in total

1.  Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1.

Authors:  Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster
Journal:  Circulation       Date:  2017-08-04       Impact factor: 29.690

Review 2.  Arterial stiffness as a risk factor for coronary artery disease.

Authors:  Josh Liao; John Farmer
Journal:  Curr Atheroscler Rep       Date:  2014-02       Impact factor: 5.113

3.  Cardiovascular disease: Questioning the effect of β-blockers on vascular stiffness.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Nat Rev Nephrol       Date:  2015-05-05       Impact factor: 28.314

4.  Arterial stiffness in patients with non-classic Pompe disease: role of antihypertensive drugs and statins.

Authors:  Ercan Varol
Journal:  J Inherit Metab Dis       Date:  2014-05-10       Impact factor: 4.982

5.  Early Wave Reflection and Pulse Wave Velocity Are Associated with Diastolic Dysfunction in Rheumatoid Arthritis.

Authors:  Lebogang Mokotedi; Sulé Gunter; Chanel Robinson; Frederic Michel; Ahmed Solomon; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Patrick H Dessein; Aletta M E Millen
Journal:  J Cardiovasc Transl Res       Date:  2019-05-22       Impact factor: 4.132

6.  Antihypertensive drugs and statins must be considered in arterial stiffness evaluation in patients with Alzheimer's disease.

Authors:  Ercan Varol
Journal:  Neurol Sci       Date:  2016-03-02       Impact factor: 3.307

Review 7.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

Review 8.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

9.  Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.

Authors:  Steven M Smith; Yan Gong; Eileen Handberg; Franz H Messerli; George L Bakris; Ali Ahmed; Anthony A Bavry; Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Hypertens       Date:  2014-03       Impact factor: 4.844

10.  To compare the effect of Telmisartan with Metoprolol on arterial stiffness in hypertension: prospective randomized parallel group trial.

Authors:  Minakshi Sumbria; Prakash C Negi; Ashok K Sahai; Purshotam K Kaundal
Journal:  Indian Heart J       Date:  2014-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.